| NCT Number | NCT06279299 |
| Lead Sponsor | National Cancer Center, China |
| Conditions | Rectal Neuroendocrine Neoplasm |
| Enrollment | 30 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2028-08-01 (estimated) |
| Study Completion | 2028-08-01 (estimated) |
| Updated on ClinicalTrials.gov | 2024-02-28 |